The area postrema is responsible for emesis and nausea and is likely the main contributor to these GLP-1 receptor agonist-associated side effects
What the Research Says BPC-157: Evidence Overview What the Research Supports (Animal Models) The majority of BPC-157 research has been conducted in rodent models and has demonstrated: Accelerated healing of tendon, ligament, and muscle injuries Gastroprotective effects against NSAID-induced ulcers and inflammatory bowel lesions Neuroprotection in models of traumatic brain injury and peripheral nerve damage Systemic anti-inflammatory activity Bone healing support and osteoblast activity enhancement The animal research for BPC-157 is genuinely compelling in breadth
Haruwaka K, Ikegami A, Tachibana Y, Ohno N, Konishi H, Hashimoto A, et al
Final Thoughts The best diet while taking a GLP-1 medication isn't complicated
Whether you are a veteran, an athlete, or simply someone focused on longevity, understanding how supplements interact with your body is non-negotiable
